Sanjeeb Kumar Sahoo
Overview
Explore the profile of Sanjeeb Kumar Sahoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahoo S, Sahoo S
Nanomedicine (Lond)
. 2024 Apr;
19(14):1227-1229.
PMID: 38686943
No abstract available.
2.
Sa P, Singh P, Panda S, Swain R, Dash R, Sahoo S
Transl Res
. 2024 Mar;
268:63-78.
PMID: 38499286
Cisplatin alone or in combination with 5FU and docetaxel is the preferred chemotherapy regimen for advanced-stage OSCC patients. However, its use has been linked to recurrence and metastasis due to...
3.
Dash S, Swain S, Khuntia A, Dutta S, Sahoo S
Curr Pharm Biotechnol
. 2024 Mar;
PMID: 38441009
Cancer is the second-leading cause of death in the 21st century, where early detection and appropriate therapeutic interventions are two components essential for effective cancer management. Despite the availability of...
4.
Singh P, Sen K, Sa P, Khuntia A, Raghav S, Swain R, et al.
Phytomedicine
. 2023 Dec;
123:155181.
PMID: 38091824
Background: Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and exhibits high rate of chemoresistance, metastasis, and relapse. This can be attributed to the failure...
5.
Thalappil M, Singh P, Carcereri de Prati A, Sahoo S, Mariotto S, Butturini E
Phytother Res
. 2023 Nov;
38(2):556-591.
PMID: 37919622
Breast Cancer (BC) is the most prevalent type of cancer in the world. Current treatments include surgery, radiation, and chemotherapy but often are associated with high toxicity to normal tissues,...
6.
Mohapatra P, Madhulika S, Behera S, Singh P, Sa P, Prasad P, et al.
Mol Ther Nucleic Acids
. 2023 Sep;
34:102031.
PMID: 37771911
Triple-negative breast cancer (TNBC) harbors a high percentage of breast cancer stem-like cells (BCSCs) that significantly contribute to poor prognosis, metastasis, and relapse of the disease. Thus, targeting BCSCs could...
7.
Sa P, Mohapatra P, Swain S, Khuntia A, Sahoo S
Mol Pharm
. 2023 Aug;
20(11):5254-5277.
PMID: 37596986
Cancer remains the leading cause of death and rapidly evolving disease worldwide. The understanding of disease pathophysiology has improved through advanced research investigation, and several therapeutic strategies are being used...
8.
Mahapatra M, Mohapatra P, Pakeeraiah K, Bandaru R, Ahmad I, Mal S, et al.
Int J Biol Macromol
. 2023 Aug;
249:126084.
PMID: 37532192
Our cascading attempt to develop new potent molecules now involves designing a series of imidazole derivatives and synthesizing two sets of 2,4,5- tri-substituted (4a-4d) and 1,2,4,5-tetra-substituted (6a-6d) imidazole by the...
9.
Sahoo S, Mohapatra P, Sahoo S
Anticancer Agents Med Chem
. 2022 Oct;
23(6):658-675.
PMID: 36284374
Breast Cancer is one of the most notorious cancer affecting women globally. Current therapies available for breast cancer treatment have certain limited efficacy; develop drug resistance and severe adverse effects....
10.
Sa P, Singh P, Dilnawaz F, Sahoo S
Curr Pharm Des
. 2022 Aug;
28(33):2742-2757.
PMID: 35909283
Drug delivery to central nervous system (CNS) diseases is one of the most challenging tasks. The innate blood-brain barrier (BBB) and the blood-cerebrospinal fluid (BCSF) barrier create an obstacle to...